(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

Nearly all the patients had Type 2 diabetes. Over three years, researchers tracked those who were prescribed either a GLP-1 drug like Ozempic or an SGLT2 medication like Jardiance after their initial ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

Viking Therapeutics (NASDAQ: VKTX) soared to center stage earlier this year as a potentially promising player in one of today's highest-growth healthcare markets: weight loss drugs. The biotech ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

The correlation between the rise of these appetite-suppressing drugs and the decline in snack sales suggests that as more ...

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.